Individual Stringent Mini Isolators for Autologous Cell Therapy

52 Ter Avenue de Saint Cloud 78000 Versailles (F), France

*Corresponding author: Didier Meyer, 52 Ter Avenue de Saint Cloud 78000 Versailles (F), France, Cell Phone: 33(0)607504088, Email: [email protected]

Received Date: September 25, 2023

Published Date: February 28, 2025

Citation: Meyer D. (2025). Individual Stringent Mini Isolators for Autologous Cell Therapy. Mathews J Pharma Sci. 9(1):45.

Copyrights: Meyer D. © (2025).

ABSTRACT

The Chimeric Antigen Receptor of T cells (CAR-T) allows through a leukapheresis, a transduction and a growth of cells to create “killer cells" against a dedicated tumour of a patient which is the donor in case of autologous CAR-T. This article presents one individual decentralised solution for solid tumours with a mix of technologies (RTP isolator, Single Use Systems, CPC connectors) at an affordable price to prevent from any contamination during the whole process before the injection of the dedicated “killer cells” to the patient.

Keywords: Autologous Cell Therapy, Blood, Environment, Patients